Navigation Links
Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
Date:5/17/2013

SAN DIEGO, May 17, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the UBS Global Healthcare Conference in New York. The presentation is scheduled for Wednesday, May 22nd at 11 a.m. Eastern Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase 3 clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase 2 clinical trials. Further information about the Company can be found at www.orexigen.com.Orexigen Contact:

Media Contact:  McDavid Stilwell

Denise PowellVP, Corporate Communications and Business Development

BrewLife(858) 875-8629

(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Orexigen Therapeutics to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2020)... ... February 19, 2020 , ... Aspire Regenerative, a leader in offering ... Wellness Pharmacy for a free weight-loss event on March 1, 2020. It will take ... La Jolla, CA, 92037. , During the event, physicians and pharmacists will lead an ...
(Date:2/19/2020)... ... February 19, 2020 , ... Cancer ... Molecular diagnostics platforms are increasingly becoming popular as they enable accurate diagnosis as ... market for molecular cancer diagnostics, including histology and assays, reached $1.6 billion, increasing ...
(Date:2/19/2020)... ... February 19, 2020 , ... The ... best colleges and universities for people with disabilities. , The Edvocate highlighted ... with disabilities succeed in higher education. AIC placed in the top ten with ...
Breaking Medicine Technology:
(Date:2/21/2020)... ... February 21, 2020 , ... The American ... Cancer Leaders’ Summit in Boston, MA, in October 2021. The prestigious, invitation-only event—organized ... including prime ministers, ministers of health, city and industry leaders, senior executives and ...
(Date:2/20/2020)... ... 20, 2020 , ... R3 Medical Training announced its next joint injection training ... to perform injections for all large and small joints along with ultrasound needle guidance. ... The best opportunity is to perform injections in a supervised setting. R3 Medical Training's ...
(Date:2/20/2020)... , ... February 20, 2020 , ... Millennial women are ... & Laser Center in Milford, Penn requesting treatments to achieve “ Rich Girl Face ... doesn’t look like it is slowing down into 2020. It’s a look inspired by ...
(Date:2/19/2020)... N.H. (PRWEB) , ... February 19, 2020 , ... ... been honored with a grant of $10,000.00 from the Doug Flutie, Jr. Foundation ... fitness program for students with autism. , The physical fitness program will include ...
(Date:2/19/2020)... ST. LOUIS (PRWEB) , ... February 19, 2020 ... ... announced the availability of and application deadline for its new Lifestyle Medicine Residency ... curriculum designed for integrated implementation into medical residency programs. Driven by resident ...
Breaking Medicine News(10 mins):